Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/99846
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Stewart, S. | - |
dc.contributor.author | Ball, J. | - |
dc.contributor.author | Horowitz, J. | - |
dc.contributor.author | Marwick, T. | - |
dc.contributor.author | Mahadevan, G. | - |
dc.contributor.author | Wong, C. | - |
dc.contributor.author | Abhayaratna, W. | - |
dc.contributor.author | Chan, Y. | - |
dc.contributor.author | Esterman, A. | - |
dc.contributor.author | Thompson, D. | - |
dc.contributor.author | Scuffham, P. | - |
dc.contributor.author | Carrington, M. | - |
dc.date.issued | 2015 | - |
dc.identifier.citation | The Lancet, 2015; 385(9970):775-784 | - |
dc.identifier.issn | 0140-6736 | - |
dc.identifier.issn | 1474-547X | - |
dc.identifier.uri | http://hdl.handle.net/2440/99846 | - |
dc.description.abstract | Background: Patients are increasingly being admitted with chronic atrial fibrillation, and disease-specific management might reduce recurrent admissions and prolong survival. However, evidence is scant to support the application of this therapeutic approach. We aimed to assess SAFETY--a management strategy that is specific to atrial fibrillation. Methods: We did a pragmatic, multicentre, randomised controlled trial in patients admitted with chronic, non-valvular atrial fibrillation (but not heart failure). Patients were recruited from three tertiary referral hospitals in Australia. 335 participants were randomly assigned by computer-generated schedule (stratified for rhythm or rate control) to either standard management (n=167) or the SAFETY intervention (n=168). Standard management consisted of routine primary care and hospital outpatient follow-up. The SAFETY intervention comprised a home visit and Holter monitoring 7-14 days after discharge by a cardiac nurse with prolonged follow-up and multidisciplinary support as needed. Clinical reviews were undertaken at 12 and 24 months (minimum follow-up). Coprimary outcomes were death or unplanned readmission (both all-cause), measured as event-free survival and the proportion of actual versus maximum days alive and out of hospital. Analyses were done on an intention-to-treat basis. The trial is registered with the Australian New Zealand Clinical Trials Registry (ANZCTRN 12610000221055). Findings: During median follow-up of 905 days (IQR 773-1050), 49 people died and 987 unplanned admissions were recorded (totalling 5530 days in hospital). 127 (76%) patients assigned to the SAFETY intervention died or had an unplanned readmission (median event-free survival 183 days [IQR 116-409]) and 137 (82%) people allocated standard management achieved a coprimary outcome (199 days [116-249]; hazard ratio 0·97, 95% CI 0·76-1·23; p=0·851). Patients assigned to the SAFETY intervention had 99·5% maximum event-free days (95% CI 99·3-99·7), equating to a median of 900 (IQR 767-1025) of 937 maximum days alive and out of hospital. By comparison, those allocated to standard management had 99·2% (95% CI 98·8-99·4) maximum event-free days, equating to a median of 860 (IQR 752-1047) of 937 maximum days alive and out of hospital (effect size 0·22, 95% CI 0·21-0·23; p=0·039). Interpretation: A post-discharge management programme specific to atrial fibrillation was associated with proportionately more days alive and out of hospital (but not prolonged event-free survival) relative to standard management. Disease-specific management is a possible strategy to improve poor health outcomes in patients admitted with chronic atrial fibrillation. Funding: National Health and Medical Research Council of Australia. | - |
dc.description.statementofresponsibility | Simon Stewart, Jocasta Ball, John D Horowitz, Thomas H Marwick, Gnanadevan Mahadevan, Chiew Wong, Walter P Abhayaratna, Yih K Chan, Adrian Esterman, David R Thompson, Paul A Scuffham, Melinda J Carrington | - |
dc.language.iso | en | - |
dc.publisher | Elsevier | - |
dc.rights | Copyright © 2015 Elsevier Ltd. All rights reserved. | - |
dc.source.uri | http://dx.doi.org/10.1016/s0140-6736(14)61992-9 | - |
dc.subject | Atrial fibrillation | - |
dc.title | Standard versus atrial fibrillation-specific management strategy (SAFETY) to reduce recurrent admission and prolong survival: pragmatic, multicentre, randomised controlled trial | - |
dc.type | Journal article | - |
dc.identifier.doi | 10.1016/S0140-6736(14)61992-9 | - |
dc.relation.grant | http://purl.org/au-research/grants/nhmrc/519823 | - |
dc.relation.grant | http://purl.org/au-research/grants/nhmrc/1041796 | - |
dc.relation.grant | http://purl.org/au-research/grants/nhmrc/1017804 | - |
dc.relation.grant | http://purl.org/au-research/grants/nhmrc/1032934 | - |
pubs.publication-status | Published | - |
dc.identifier.orcid | Stewart, S. [0000-0001-9032-8998] | - |
dc.identifier.orcid | Horowitz, J. [0000-0001-6883-0703] | - |
dc.identifier.orcid | Esterman, A. [0000-0001-7324-9171] | - |
Appears in Collections: | Aurora harvest 3 Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.